Topic Menu
► Topic MenuTopic Editors


Cancer Stem Cells, DNA Methylation and DNA Sequences: Their Diagnostic and Therapeutical Applications
Topic Information
Dear Colleagues,
DNA methylation is an essential epigenetic mechanism for controlling gene expression in both embryonic and adult stem cells. There is a fine-tuned balance between the regulation of gene activation and repression during normal cellular activity, and either hypo- or hypermethylation could induce the expression or inhibition of genes, respectively. Changes in methylation status are acknowledged to be hallmarks for cancer initiation and progression, with the potential to transform normal stem cells into a cancer stem cell (CSC) phenotype. The basic function of the immune system is to provide the host with protection from invading foreign antigens in parallel with the state of self-tolerance, i.e., maintaining its unique antigenic profile. Cellular structures such as nuclei and mitochondria house the vast bulk of DNA. Changes in DNA sequences have gained attention as potential biomarkers since they can be detected as extracellular cell-free DNA (cfDNA) in a wide range of diseases, including cancer. Recently, cfDNA testing has seen a resurgence due to the widespread use of liquid biopsies and the growing need for disease screening, activity monitoring, and drug response assessments. Studies on the immunological effects of cfDNA, in addition to their immunomodulatory or therapeutic advantages, are still in their infancy. The main aim of this Special Issue (Topic) is to discuss the impact of aberrant DNA methylation statuses on CSC functions, including self-renewal, differentiation, drug resistance, and metastasis formation, in addition to analyzing recent findings on the role of different DNA-sensing receptors in the recognition of foreign or self-DNA sequences as potent danger-associated molecular patterns. Further, emphasizing the immunomodulatory as well as pro- and anti-tumor capacities of different DNA sequences, and thus their subsequent potential for anticancer therapy, this Special Issue (Topic) also intends to summarize the results of recent experimental studies.
Dr. Ferenc Sipos
Dr. Györgyi Műzes
Topic Editors
Keywords
- cancer stem cells
- DNA methylation
- epigenome
- drug resistance
- metastasis
- self-renewal
- hypermethylation
- hypomethylation
- DNA sequence
- cell-free DNA
- DNA sensing
- methylation signatures
- differentially methylated probes or regions
- diagnostic performance
- therapy
- liquid biopsy
- DNA methylation technologies
- tissue of origin (TOO)
- CpG oligonucleotides
- toll-like receptor 9
- absent in melanoma-2
- cyclic GMP–AMP synthase
- tumor microenvironment
Participating Journals
Journal Name | Impact Factor | CiteScore | Launched Year | First Decision (median) | APC |
---|---|---|---|---|---|
![]()
Biomedicines
|
3.9 | 5.2 | 2013 | 14.6 Days | CHF 2600 |
![]()
Cancers
|
4.5 | 8.0 | 2009 | 17.4 Days | CHF 2900 |
![]()
Cells
|
5.1 | 9.9 | 2012 | 17 Days | CHF 2700 |
![]()
Journal of Clinical Medicine
|
3.0 | 5.7 | 2012 | 16 Days | CHF 2600 |
![]()
Pharmaceutics
|
4.9 | 7.9 | 2009 | 15.5 Days | CHF 2900 |
![]()
Reports
|
0.8 | - | 2018 | 18.6 Days | CHF 1400 |
Preprints.org is a multidisciplinary platform offering a preprint service designed to facilitate the early sharing of your research. It supports and empowers your research journey from the very beginning.
MDPI Topics is collaborating with Preprints.org and has established a direct connection between MDPI journals and the platform. Authors are encouraged to take advantage of this opportunity by posting their preprints at Preprints.org prior to publication:
- Share your research immediately: disseminate your ideas prior to publication and establish priority for your work.
- Safeguard your intellectual contribution: Protect your ideas with a time-stamped preprint that serves as proof of your research timeline.
- Boost visibility and impact: Increase the reach and influence of your research by making it accessible to a global audience.
- Gain early feedback: Receive valuable input and insights from peers before submitting to a journal.
- Ensure broad indexing: Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.